Here we show that combined inhibition of EZH2 and DOT1L HMTs with the small molecule inhibitors, SGC0946 and GSK343, synergistically drive a rapid ER stress response in NB cells, amino acid depletion, and reduced tumour growth in preclinical models suggesting a novel therapeutic strategy for NB. Here, DOT1L is linked to neoplasm.